CRL Charles River Laboratories International, Inc.

NYSE
$333.25

Charles River Laboratories International, Inc. (CRL) is expected to report earnings on February 3, 2027, before the market open. The consensus earnings estimate is $3.25 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of -4.8% since its last earnings release on November 4, 2026.

Charles River Laboratories International Beat Expectations, Raises Guidance, but Earnings Remain In-line with Estimates
Wednesday, November 4, 2026 · 7:00 AM ET
Earnings Date
4th Quarter, Dec 2026
Feb 3
Wednesday · 7:00 AM ET
Earnings Whisper
-
vs $3.25
Rev est $963.94M
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP $333.96

Sign in or subscribe to unlock sentiment, short interest, and technical indicators.

About Charles River Laboratories International, Inc.

Charles River Laboratories International Inc provides research models and services required to enable in vivo drug discovery and development.

Sector

Healthcare

Industry

Research Services

Charts powered in part by Lightweight Charts™ by TradingView.